logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
JBIO
Jade Biosciences, Inc.
21.81
2 x 15.98
2 x 27.73
bid
ask
-
0.41
1.85%
2 @ 04:00 PM
21.72 -0.09 (0.41%)
Ytd41.35%
1y101.01%
21.48
day range
22.70
6.67
52 week range
28.00
Open22.38Prev Close22.22Low21.48High22.70Mkt Cap1.33B
Vol774.38KAvg Vol979.72KEPS-2.63P/EN/AForward P/E-9.75
BetaN/AShort Ratio4.37Inst. Own84.82%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-1450-d Avg21.45200-d Avg15.211yr Est48.50

JBIO News

Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
globenewswire.com
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors

SAN FRANCISCO and VANCOUVER, British Columbia, June 26, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, I
benzinga.com
UBS Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $45

UBS analyst Michael Yee initiates coverage on Jade Biosciences (NASDAQ:JBIO) with a Buy rating an

Stock Market Today: S&P 500, Dow, Nasdaq Futures Fall As House Challenges Trump's Military Authority— Broadcom, CrowdStrike In Focus (UPDATED)
benzinga.com
Stock Market Today: S&P 500, Dow, Nasdaq Futures Fall As House Challenges Trump's Military Authority

(Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the st
benzinga.com
Reported Earlier, Jade Biosciences Prices $150M Stock Offering Of 10M Shares at $15 Each

Jade Biosciences, Inc. ("Jade" or the "Company") (NASDAQ:JBIO), a clinical-stage bio

Ciena, Docusign And 3 Stocks To Watch Heading Into Thursday
benzinga.com
Ciena, Docusign And 3 Stocks To Watch Heading Into Thursday

Stocks to watch: CIEN, DOCU, LULU, report earnings today. MRAAF introduces world's first 100Vdc

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
Jade Biosciences Reveals Proposed Underwritten Public Offering; No Size Disclosed

Jade Biosciences, Inc. ("Jade" or the "Company") (NASDAQ:JBIO), a clinical-stage bio
benzinga.com
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $45

Wedbush analyst Laura Chico maintains Jade Biosciences (NASDAQ:JBIO) with a Outperform and raises

Why Is Jade Biosciences Stock Trading Lower On Monday?
benzinga.com
Why Is Jade Biosciences Stock Trading Lower On Monday?

Jade Biosciences reports Phase 1 JADE101 data showing sustained IgA reductions in IgAN, while analys
benzinga.com
BTIG Maintains Buy on Jade Biosciences, Raises Price Target to $74

BTIG analyst Julian Harrison maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and raises the p
benzinga.com
HC Wainwright & Co. Maintains Buy on Jade Biosciences, Raises Price Target to $55

HC Wainwright & Co. analyst Arthur He maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and

Taylor Morrison Home Surges On Berkshire Hathaway Acquisition, Joins Elmet Group And Other Big Stocks Moving Higher In Monday's Session
benzinga.com
Taylor Morrison Home Surges On Berkshire Hathaway Acquisition, Joins Elmet Group And Other Big Stock

U.S. stock futures up, Nasdaq surges 0.35%, with Taylor Morrison's buyout announcement. Other pr
benzinga.com
jade Biosciences Announces Interim Results From Its Phase 1 Trial Evaluating JADE101, A Novel, Inves

JADE101 is designed with ultra-high binding affinity to selectively block APRIL, a key driver of pat